Sana Rukh1, Renuka Khurana, Tom Mickey, Larissa Anderson, Corinne Velasquez, Melanie Taylor. 1. From the *Mel and Enid Zuckerman College of Public Health, University of Arizona, Phoenix, AZ; †Maricopa County Department of Public Health, Phoenix, AZ; ‡Arizona Department of Health Services, Phoenix, AZ; and §Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA.
Abstract
BACKGROUND: The demand for low-cost sexually transmitted disease (STD) services in Maricopa County (Phoenix area) is high. Improved methods for STD/HIV testing are needed to increase the number of patients receiving testing. OBJECTIVES: The present study sought to evaluate an STD/HIV express testing (ET) option for patients identified as being at lower risk for infection. METHODS: Clients reporting current STD symptoms, contact to an infected partner, or health department referral were identified via questionnaire and routed to a traditional provider visit (PV); those not reporting these situations were routed to ET (laboratory-only). Demographics, treatment completion, and treatment intervals were compared among patients diagnosed as having chlamydia and gonorrhea through ET and PV encounters in September 2008 to July 2011. Personnel costs were compared for each of the 2 visit types. The number of clinic turn-aways for the 2-month time interval before the start of the program was compared with the 2-month interval at the end of the evaluation. RESULTS: Of the 36,946 clients seen at Maricopa County Department of Public Health, 7466 (20.2%) were patients seen through express visits. Overall chlamydia and gonorrhea positivity was lower among ET patients (527/7466; 7.1%) as compared with those tested through PVs (6323/29,480; 21.4%). Treatment completion rates were comparable but were higher among patients seen through PVs (99%) as compared with ET (94%). A savings of $2936 per 1000 patients seen was achieved when 20% of clients were routed through ET. Clinic turn-aways decreased significantly, from 159 clients during the 2 months before implementation of ET to 6 patients during the last 2 months of evaluation (96% reduction). CONCLUSIONS: This ET system included an effective patient routing process that provided an efficient way to increase access to STD testing among persons at lower risk, at a reduced cost per patient, while maintaining high treatment coverage.
BACKGROUND: The demand for low-cost sexually transmitted disease (STD) services in Maricopa County (Phoenix area) is high. Improved methods for STD/HIV testing are needed to increase the number of patients receiving testing. OBJECTIVES: The present study sought to evaluate an STD/HIV express testing (ET) option for patients identified as being at lower risk for infection. METHODS: Clients reporting current STD symptoms, contact to an infected partner, or health department referral were identified via questionnaire and routed to a traditional provider visit (PV); those not reporting these situations were routed to ET (laboratory-only). Demographics, treatment completion, and treatment intervals were compared among patients diagnosed as having chlamydia and gonorrhea through ET and PV encounters in September 2008 to July 2011. Personnel costs were compared for each of the 2 visit types. The number of clinic turn-aways for the 2-month time interval before the start of the program was compared with the 2-month interval at the end of the evaluation. RESULTS: Of the 36,946 clients seen at Maricopa County Department of Public Health, 7466 (20.2%) were patients seen through express visits. Overall chlamydia and gonorrhea positivity was lower among ETpatients (527/7466; 7.1%) as compared with those tested through PVs (6323/29,480; 21.4%). Treatment completion rates were comparable but were higher among patients seen through PVs (99%) as compared with ET (94%). A savings of $2936 per 1000 patients seen was achieved when 20% of clients were routed through ET. Clinic turn-aways decreased significantly, from 159 clients during the 2 months before implementation of ET to 6 patients during the last 2 months of evaluation (96% reduction). CONCLUSIONS: This ET system included an effective patient routing process that provided an efficient way to increase access to STD testing among persons at lower risk, at a reduced cost per patient, while maintaining high treatment coverage.
Authors: Rachel Paneth-Pollak; Julia A Schillinger; Jessica M Borrelli; Shoshanna Handel; Preeti Pathela; And Susan Blank Journal: Am J Public Health Date: 2010-02-18 Impact factor: 9.308
Authors: Sanny Y Chen; Michelle Johnson; Rebecca Sunenshine; Bob England; Ken Komatsu; Melanie Taylor Journal: Sex Transm Dis Date: 2009-07 Impact factor: 2.830
Authors: David Wong; Stuart M Berman; Bruce W Furness; Robert A Gunn; Melanie Taylor; Thomas A Peterman Journal: Sex Transm Dis Date: 2005-03 Impact factor: 2.830
Authors: Sara J Shamos; Christie J Mettenbrink; Julie A Subiadur; Brandy L Mitchell; Cornelis A Rietmeijer Journal: Sex Transm Dis Date: 2008-04 Impact factor: 2.830
Authors: Kwame Owusu-Edusei; Harrell W Chesson; Thomas L Gift; Guoyu Tao; Reena Mahajan; Marie Cheryl Bañez Ocfemia; Charlotte K Kent Journal: Sex Transm Dis Date: 2013-03 Impact factor: 2.830
Authors: Laura C Chambers; Lisa E Manhart; David A Katz; Matthew R Golden; Lindley A Barbee; Julia C Dombrowski Journal: Sex Transm Dis Date: 2018-10 Impact factor: 2.830
Authors: Michael Sang Hughes; Andria Apostolou; Brigg Reilley; Jessica Leston; Jeffrey McCollum; Jonathan Iralu Journal: Public Health Rep Date: 2020-12-10 Impact factor: 2.792
Authors: Rebecca Earnest; Minttu M Rönn; Meghan Bellerose; Anatole S Menon-Johansson; Andrés A Berruti; Harrell W Chesson; Thomas L Gift; Katherine K Hsu; Christian Testa; Lin Zhu; Yelena Malyuta; Nicolas A Menzies; Joshua A Salomon Journal: Sex Transm Dis Date: 2021-11-01 Impact factor: 3.868
Authors: Pei Zhen Zhao; Ya Jie Wang; Huan Huan Cheng; Ye Zhang; Wei Ming Tang; Fan Yang; Wei Zhang; Ji Yuan Zhou; Cheng Wang Journal: BMC Public Health Date: 2021-07-28 Impact factor: 3.295